levonordefrin; procaine hydrochloride; propoxycaine hydrochloride
Drug data last refreshed 20h ago · AI intelligence enriched 3d ago
RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN is a combination injectable local anesthetic containing procaine hydrochloride, propoxycaine hydrochloride, and the vasoconstrictor levonordefrin. It is indicated for infiltration anesthesia and nerve blocks in dental and surgical procedures. The vasoconstrictive component extends the duration of anesthesia by reducing local blood flow.
This vintage 1952 injectable faces moderate competitive pressure (score: 30) with minimal linked job opportunities, indicating a mature, stable franchise with small commercial teams.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on this product offers stability in a mature injectable portfolio but limited growth prospects; roles focus on operational efficiency, cost management, and market maintenance rather than expansion. Career progression may require cross-training on newer franchise assets or transition to adjacent product lines.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.